Novel Agent Reduces Antithrombin Levels to Treat Hemophilia Novel Agent Reduces Antithrombin Levels to Treat Hemophilia

Fitusiran, an RNA interference agent, safely reduces antithrombin levels to allow clot formation to treat hemophilia A or B in patients with or without inhibitors, a study shows.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Cardiology News Source Type: news